Correlation Between Max Healthcare and Akums Drugs

Can any of the company-specific risk be diversified away by investing in both Max Healthcare and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Max Healthcare and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Max Healthcare Institute and Akums Drugs and, you can compare the effects of market volatilities on Max Healthcare and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Max Healthcare with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Max Healthcare and Akums Drugs.

Diversification Opportunities for Max Healthcare and Akums Drugs

-0.68

Correlation Coefficient

Max Healthcare  Akums Drugs

Excellent diversification

The 3 months correlation between Max and Akums is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Max Healthcare Institute and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Max Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Max Healthcare Institute are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Max Healthcare i.e., Max Healthcare and Akums Drugs go up and down completely randomly.

Pair Corralation between Max Healthcare and Akums Drugs

Assuming the 90 days trading horizon Max Healthcare Institute is expected to generate 0.65 times more return on investment than Akums Drugs. However, Max Healthcare Institute is 1.55 times less risky than Akums Drugs. It trades about 0.17 of its potential returns per unit of risk. Akums Drugs and is currently generating about 0.03 per unit of risk. If you would invest  113,220  in Max Healthcare Institute on October 12, 2024 and sell it today you would earn a total of  7,640  from holding Max Healthcare Institute or generate 6.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Max Healthcare Institute  vs.  Akums Drugs and

Max Healthcare Institute

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Max Healthcare Institute are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady essential indicators, Max Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.

Akums Drugs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Max Healthcare and Akums Drugs

The main advantage of trading using opposite Max Healthcare and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Max Healthcare position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.

The idea behind Max Healthcare Institute and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.